Unusual Volume At Healthcare: Zogenix (NASDAQ:ZGNX), Sunshine Heart (NASDAQ:SSH), Tengion (OTCMKTS:TNGN), Myrexis Inc. (OTCMKTS:MYRX)

Zogenix, Inc. (NASDAQ:ZGNX) reported Q4 EPS of ($0.13), $0.03 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $9.9 million versus the consensus estimate of $8.68 million. Zogenix, Inc. (NASDAQ:ZGNX) stock opened at $4.03 in last session, and closed at $4.54, while the day range of Zogenix, Inc. (NASDAQ:ZGNX) stock is $4.03 – $4.68. The stock showed a positive weekly performance of 0.22%.

Sunshine Heart, Inc. (NASDAQ:SSH) on 11 march announced its financial results and provided a corporate update for the fourth quarter and full-year ended December 31, 2013. Sunshine Heart Inc. (NASDAQ:SSH) stock opened at $7.19 in last session, and closed at $6.26 by losing -22.43%. The 52 week range of $4.85 – $13.80. Company’s market capitalization is $79.70 million.

Tengion, Inc. (OTCMKTS:OTGN) is a regenerative medicine company focused on discovering, developing, manufacturing and commercializing a range of replacement organs and tissues, or neo-organs and neo-tissues. Tengion, Inc. (OTCMKTS:TNGN) stock increased 2.19% and finished the last session at $0.233. The EPS of the stock remained -9.77. Company’s market capitalization is $0.58 million.

Myrexis Inc. (OTCMKTS:MYRX) is a biopharmaceutical company that has generated a pipeline of differentiated drug candidates in oncology and autoimmune diseases. The Company retains all rights to all of its drug candidates and programs across all geographic markets and therapeutic indications. Myrexis Inc. (OTCMKTS:MYRX) stock opened the session at $0.16, and closed the session at $0.160. The 52 week range of the Myrexis Inc. (OTCMKTS:MYRX) stock remained $0.06 – $0.24 and the day range was $0.16 – $0.20.